DR Muylle-Nucleaire Geneeskunde & DR Reynd… SRL
DR Muylle-Nucleaire Geneeskunde & DR Reynd… reported total assets of €1.74m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Sep 2026).
By total assets for 2025, DR Muylle-Nucleaire Geneeskunde & DR Reynd… ranks among the 500 largest of the 9,917 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of DR Muylle-Nucleaire Geneeskunde & DR Reynd… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR Muylle-Nucleaire Geneeskunde & DR Reynd…'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 166,200 € | ||||
| Equity | 977,009 € | ||||
| Cash | 113,174 € | ||||
| EBITDA | 352,725 € | ||||
| Total assets | €1.74m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Sep 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 27 Sep 2024
- Year ended 31 Dec 2022filed on 09 Oct 2023
- Year ended 31 Dec 2021filed on 26 Sep 2022
DR Muylle-Nucleaire Geneeskunde & DR Reynd…'s financial analysis
- Solvency56.3%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR Muylle-Nucleaire Geneeskunde & DR Reynd…
2 active director(s) in the register.
DR Muylle-Nucleaire Geneeskunde & DR Reynd…'s shareholders and holdings →DR Muylle-Nucleaire Geneeskunde & DR Reynd…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0828.298.539
- VAT number
- BE0828298539
- Peppol
- Registered · 0208:0828298539 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Aug 2010
- Registered office
- 9991 Maldegem
- Latest accounts
- 2025 · filed on 25 Sep 2026
- Activity
- General medical practice activities (NACE 86210)
DR Muylle-Nucleaire Geneeskunde & DR Reynd… (SRL) has been based in Maldegem since 2010, active in: general medical practice activities. For 2025, it reports a net profit of 166,200 € and equity of 977,009 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR Muylle-Nucleaire Geneeskunde & DR Reynd…
Companies in the same business, of comparable size and area, outside its group.
- Huisarts Piet van Haute General medical practice activities Bruges · balance sheet €1.53m
- Dokter Schelstraete Björn Research and experimental development on natural sciences and engineering Wingene · balance sheet €1.83m
- Declerck Fredelinde Dr. General medical practice activities Lichtervelde · balance sheet 696,654 €
- Grosjean General medical practice activities Charleroi · balance sheet 633,561 €
- Dr. Jan van Langendonck General medical practice activities Hasselt · balance sheet 609,365 €
- Cabinet Medical Virginie Dumont General medical practice activities Anthisnes · balance sheet 920,210 €
- Dr. Tempels General medical practice activities Scherpenheuvel-Zichem · balance sheet €1.59m
- Dr. Van Hove Lieven General medical practice activities Gingelom · balance sheet €1.53m
Frequently asked questions about DR Muylle-Nucleaire Geneeskunde & DR Reynd…
What is the revenue of DR Muylle-Nucleaire Geneeskunde & DR Reynd…?
DR Muylle-Nucleaire Geneeskunde & DR Reynd… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR Muylle-Nucleaire Geneeskunde & DR Reynd…?
In Belgium, the VAT number is the company number prefixed with BE: BE0828298539 for DR Muylle-Nucleaire Geneeskunde & DR Reynd…, if the company is VAT-registered. Its company number (CBE) is 0828.298.539.
Where is the registered office of DR Muylle-Nucleaire Geneeskunde & DR Reynd…?
According to the CBE register, the registered office of DR Muylle-Nucleaire Geneeskunde & DR Reynd… is in 9991 Maldegem.
What is the equity of DR Muylle-Nucleaire Geneeskunde & DR Reynd…?
At the close of the 2025 financial year, the equity of DR Muylle-Nucleaire Geneeskunde & DR Reynd… amounts to 977,009 €, a solvency of 56.3% of total assets.
Who manages DR Muylle-Nucleaire Geneeskunde & DR Reynd…?
The register lists 2 active mandates at DR Muylle-Nucleaire Geneeskunde & DR Reynd…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is DR Muylle-Nucleaire Geneeskunde & DR Reynd… within its sector?
By total assets for 2025, DR Muylle-Nucleaire Geneeskunde & DR Reynd… ranks among the 500 largest of the 9,917 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.
The full file of DR Muylle-Nucleaire Geneeskunde & DR Reynd…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →